We further analyzed the power of FBXO39 and CEP55 in the prognosis of GBM using our cohort and found the existence of a trend toward worse overall survival in GBM patients with high expression of FBXO39 (Fig 6a; S4 File). This evidence concerns the gene FBXO39 and glioblastoma.